Back to available technologies

Novel Therapy for Treating Glaucoma

Controlled release dosage formulations for the delivery of active agents, especially for treatment of eye diseases or disorders, such as glaucoma, have been developed. These provide release of the active agent, such as ECA or a derivative thereof, for an effective period of time.

Duke File (IDF) Number

T-004270

Inventor(s)

  • Walsh, Molly
  • Epstein, David
  • Hanes, Justin

For more information please contact

College

School of Medicine (SOM)

Interested in this Technology?

Submit your interest below.